All Industries

Peru Moda Deco New York 2025: World-Class Sourcing for a New Era

Promperu

Backed by decades of textile expertise and global recognition, Peru's industry is stepping confidently onto the international stage. This May 1st, the vibrant strength of Peru’s textile and home decor will converge in New York City for Peru Moda Deco New York 2025, a premier B2B business matchmaking event connecting 50 of Peru's leading apparel and home decor companies with 118 international buyers. Organized by PROMPERÚ, Peru's Commission for the Promotion of Exports and Tourism, Peru Moda Deco New York showcases the best of Peru's innovation, sustainability, and craftsmanship. At a time when global sourcing strategies are evolving, Peru emerges as a reliable, high-quality alternative for international buyers seeking to diversify their supply chains. Today, Peru's experienced business leaders are driving the industry forward through advanced industrialization and technological innovation, while preserving artisanal techniques and attention to detail that ensure exceptional quality. The showcase spans apparel, accessories, footwear, homeware, and gifts, featuring standout categories like Peruvian Pima cotton garments, baby and children's apparel, alpaca knitwear, and innovative home decor. Buyers representing global fashion and retail brands, including Brooks Brothers, Alexander Wang, Victoria's Secret, and Revolve, will connect with Peruvian companies that blend proven expertise with modern demands. Behind each collection lies Peru's exceptional access to premium raw materials. Home to the world's finest Pima and Tanguis cotton and luxurious alpaca fibers, Peru offers a palette unmatched in quality and sustainability. But the true strength lies in the vision and commitment of Peruvian business leaders, many heading established SMEs deeply focused on personalized service, high international standards, and sustainable production practices. A special sustainability seminar featuring leading Peruvian exporters will also engage fashion students in New York, showcasing how innovation and responsibility can forge a more ethical and forward-thinking industry. The event is part of a broader strategy to strengthen Peru's footprint in North America, its top destination for fashion and decor exports. In 2024, the United States accounted for 50.1% of these exports, valued at USD 803 million — reflecting growing recognition of Peru's excellence in quality, design, and sustainable production. In a global fashion world increasingly demanding transparency, Peru’s vertically integrated, innovation-driven industry provides both exceptional products and reliable strategic partnerships. Peru Moda Deco New York 2025 stands as a gateway to building strong commercial ties, accessing exceptional sourcing opportunities, and connecting with Peruvian companies committed to the highest standards of quality, innovation, and sustainability. Peru Export and Tourism Promotion Board (PROMPERÚ). We are the government agency in charge of the development and implementation of global strategies to position Peru via the promotion of its image, touristic destinations, added value exports and investments. Contact Details José Carlos Collazos jcollazos@promperu.gob.pe Company Website http://www.promperu.gob.pe

April 29, 2025 10:32 AM Eastern Daylight Time

Bizee Releases The Ultimate Guide to Startup Success by Amy Cosper

Bizee

Bizee, a leader in online business formation services, today announced the launch of The Ultimate Guide to Startup Success by Amy Cosper, former editor-in-chief of Entrepreneur magazine and a globally recognized voice in entrepreneurship. The book delivers a no-nonsense, step-by-step playbook for anyone ready to turn their idea into a real business. “Entrepreneurs are full of ideas, grit, and ambition, but the process of actually starting a business can feel like a maze,” Cosper said. “This book cuts through the noise. It gives you the tools, the steps, and the confidence to turn your idea into something real.” Backed by Bizee’s two decades of experience helping over a million entrepreneurs launch their businesses, The Ultimate Guide to Startup Success distills essential insights from legal, financial, and business experts into one accessible, actionable volume. It’s built to move founders from inspiration to execution without overwhelming them. Inside the book, readers will learn how to: Choose the right legal structure for their business Protect their brand from day one Raise capital and pitch with confidence Build a team and grow sustainably Avoid common pitfalls and stay compliant “This book is an extension of what Bizee was built to do—empower entrepreneurs,” said Dustin Ray, Chief Branding Officer of Bizee. “Whether you're just getting started or looking to scale, this guide gives you the roadmap and real-world advice to make it happen.” Cosper brings unmatched experience to this project. As the longtime editor-in-chief of Entrepreneur, she’s helped to shape the conversation around startup success for over a decade. Today, as Head of Content at Bizee, Cosper continues to champion the creator economy and the next generation of founders. The Ultimate Guide to Startup Success is available now on Amazon and wherever books are sold. About Bizee Bizee is a leading platform for business formation and compliance services. Since 2004, the company has supported over 1 million entrepreneurs with a streamlined, online-first approach to launching and growing a business. With $0 LLC formation, a free year of registered agent service, and no hidden fees, Bizee is built for the modern entrepreneur. Contact Details For Bizee Peter Page, VOCATUS ppage@vocatusllc.com Company Website https://bizee.com/

April 29, 2025 10:30 AM Eastern Daylight Time

Ballast Rock Launches the Ballast Rock Real Estate Private Credit Fund

Ballast Rock

Ballast Rock, the diversified investment management firm, announced today that it has launched the Ballast Rock Real Estate Private Credit Fund, which seeks to lend to small to medium-scale real estate and solar projects on a senior-secured basis, managed by preferred developers. Investments in the fund, which targets raising a maximum of $50 million, will focus on senior-secured debt instruments with the potential for some equity upside. “Ballast Rock’s long-standing track record in real estate, infrastructure development, and capital structuring gives our investment team a strong foundation to enter private credit,” said Simon O’Shea, Chief Investment Officer of Ballast Rock. “Investors in our private equity and venture capital funds have long encouraged us to explore opportunities in private credit, so we feel a fund that can benefit from our deep experience in real estate and infrastructure was a natural next step.” The new fund will be managed by Max Jackson, who recently joined Ballast Rock Asset Management as Managing Director and Private Credit Portfolio Manager. The Ballast Rock Real Estate Private Credit Fund will focus on four strategies: Lot Banking. The fund will acquire parcels of land at or below market value from developers, with developers legally required to buy back the parcels when ready for construction. Delaware Statutory Trust Financing. DST sponsors are required to provide 100% of the capital needed to acquire an asset when a DST is formed. The fund will provide short-term bridge financing to sponsors for the required capital. Franchise Location Development. The fund will provide “last mile” development capital to preferred franchise developers, secured by the underlying property. Commercial Solar Development. The fund will provide “last mile” development capital to solar developers, to be sold to solar owner-operators after completion. “We believe having a focused approach to our investments, in areas where we have experience, is a differentiator in a private credit market with many new entrants,” Jackson said. “In addition, we plan to target loan sizes of $5 million or less, since we view that market as underserved.” The fund plans to generally require a senior-secured and/or preferred position in all loans, with the goal to be the first to receive proceeds from investment monetization. The fund also expects short-term hold periods of 6 to 18 months for each investment. The Ballast Rock Real Estate Private Credit Fund will be available to U.S. accredited investors with a minimum investment of $50,000. To learn more about the fund and to read important disclosures, please visit our Investor Portal. About Ballast Rock Group Ballast Rock is an integrated investment management company specializing in delivering risk-adjusted returns, accurate, and timely advice, high quality frequent reporting, and direct access to management. Ballast Rock operates Ballast Rock Asset Management, Ballast Rock Private Wealth, and Ballast Rock Capital. Ballast Rock Asset Management comprises Ballast Rock Real Estate, which includes the firm’s Sunbelt multifamily real estate funds, and Ballast Rock Ventures, comprising venture capital and private equity teams. Ballast Rock Private Wealth is a full-service registered investment advisor, with a focus on allocating into private asset classes. Ballast Rock Capital (member FINRA / SIPC ) is an SEC-registered broker-dealer. Ballast Rock is committed to being a driver of positive change. The diversity of our team members brings valuable new perspectives to our industry for the benefit of our stakeholders and the broader community. Investment Disclosure The information contained in this press release has been prepared by Ballast Rock Holdings LLC (“Ballast Rock”) without reference to any particular reader’s investment requirements or financial situation. Potential investors are encouraged to consult with professional tax, legal, and financial advisors before making any investment into a private offering of securities. An investment in private securities would be speculative and would involve a high degree of risk. Investors must be prepared to bear the economic risk of such an investment for an indefinite period of time and be able to withstand a total loss of their investment. Please carefully consider the investment objectives, risks, transaction costs, and other expenses related to an investment prior to deciding to invest. Ballast Rock Capital LLC (“BRC”), MEMBER: FINRA / SIPC. BRC’s registered head office is 460 King Street, Suite 200, Charleston, SC, 29403. Tel: 800-204-2513. To check background information about BRC and its representatives, visit FINRA’s BrokerCheck. Please see important disclosure information in our Form CRS. Contact Details For Ballast Rock Lisa Aldape, Vocatus laldape@vocatusllc.com Company Website https://www.ballastrock.com/

April 29, 2025 10:00 AM Eastern Daylight Time

Jord BioScience Field Trials Deliver Breakthrough Consistency in Biological Crop Protection, Boosting Soybean Yields Across Midwest

Jord BioScience

Jord BioScience, a leading science and analytics company providing customizable microbial solutions for agriculture, unveiled two years of field trial data showing its proprietary microbial solutions consistently outperform industry-standard treatments, increasing soybean yield by up to 3.1 bushels per acre across 16 Midwest locations–even under dramatically different weather conditions. The company’s approach, powered by its 6,500-isolate global microbial bank and advanced analytics, demonstrated win-rates* exceeding 80% and improved performance over leading biological and chemical benchmarks by 11 percent to 25 percent, signaling a new era of reliable, field-ready biologicals for farmers facing mounting pressures to deliver higher productivity and sustainability. “Jord BioScience is committed to discovery of microbial solutions that consistently improve return on investment, while improving plant and soil health,” said Dr. Keri Carstens, president and CEO at Jord BioScience. “Our field data show that our microbial leads not only outperform current benchmarks but also provide much-needed reliability for farmers seeking sustainable, high-performing crop inputs. Through partnerships with leading agribusinesses, we aim to be a trusted, science-driven partner to advance better and more consistent crop protection products.” By understanding how microbes, as living entities, work in the soil to enhance or detract from each other, Jord BioScience is creating solutions that have a superior win-rate in the field. Unlike a chemistry-based application approach, where a product is applied everywhere at the same rate, Jord sees a much higher win-rate when identifying microbial interactions that complement each other biologically. “In two drastically different growing seasons, our microbial leads consistently delivered yield improvements and high win rates—even in high-yield environments where biologicals rarely show ROI,” said Andrea Arias, vice president of Data Science and Crop Testing. “This consistency is a game-changer for growers seeking reliable biological crop protection.” For the past two years, Jord has studied five microbial leads in soybean seed treatments to identify biological ingredients that can spur emergence, plant health and yield. Across 16 locations in Iowa, Minnesota, South Dakota and Illinois, Jord’s microbial leads, integrated into standard commercial soybean seed treatments, delivered yield increases of 1.4 to 3.1 bushels per acre during both the drought-affected 2023 season and the wet 2024 season. Quality Microbials Discovery for Fast-Tracked Crop Protection Solutions “In December of 2022, we set a goal to improve performance for a current market-leading microbial product, and to do that with a faster developmental timeline than traditional products,” said Carstens. “By March 2023, our team had identified five microbial leads that were ready to use in replicated field trials. That level of speed and productivity is unheard of in the agricultural research space.” Jord’s discovery process aims to address challenges by optimizing the microbial network that plants rely on for growth. By identifying how microbes work together to enhance microbial activities in the soil, Jord inoculants help boost plant productivity. Jord goes even further by screening for leads that will satisfy regulatory and fermentation scalability benchmarks at the beginning of the process, ensuring product quality end-to-end. “When creating the Jord BioScience Microbial Bank, our founder and Chief Science Officer, Dr. Linda Kinkel was very specific in sourcing microbes strategically from diverse global agriculturally relevant locations. Dr. Kinkel’s rigorous selection process contributes to Jord’s high success rate in finding solutions for a variety of problems in the field,” Arias said. Jord BioScience’ s proprietary technology and custom solutions are available to commercialize, by incorporating with products in the market to extend lifecycle, or to partner with microbials in the development pipeline to enhance crop performance, drive more consistent results and expand market adoption. In addition, Jord can create entirely new products that introduce novel activity, offering further opportunities for differentiation and market growth. For more information about Jord BioScience, visit jordbioscience.com. *Win rate is calculated as the number of locations with a 0.5 bu/ac advantage over the leading biological and chemistry (Treatment 3) over the total number of locations. About Jord BioScience Jord BioScience, founded on research from the University of Minnesota, is a science and analytics company developing cutting-edge microbial technologies to enhance crop productivity and sustainability in agriculture. The company leverages over three decades of research by Dr. Linda Kinkel and her team, who collected thousands of unique soil microbes globally. Jord's proprietary technology and custom formulations are designed to extend product lifecycles, enhance crop performance, and expand market adoption of microbial solutions. From product concept through commercialization, Jord BioScience fast-tracks novel product development, reducing discovery from years to less than 10 months. This approach maximizes value and results in today's competitive marketplace. The company is currently conducting product development trials in the U.S., Argentina, and Brazil. For more information, visit www.jordbioscience.com Contact Details AgTech PR for Jord BioScience Jennifer Goldston jennifer@agtechpr.com Company Website https://www.jordbioscience.com

April 29, 2025 09:30 AM Eastern Daylight Time

Image

Roberts & Ryan Earns Prestigious VETS Indexes 5-Star Employer Award for 2025

Roberts & Ryan, Inc.

Roberts & Ryan, Inc., a Service-Disabled Veteran-Owned broker-dealer, is honored to receive the 2025 VETS Indexes 5-Star Employer Award — one of the program’s highest distinctions. This award celebrates the firm’s strong and ongoing dedication to hiring, developing, and supporting veterans, military spouses, and members of the National Guard and Reserves. The VETS Indexes 5-Star Employer distinction is reserved for organizations that demonstrate a sustained and comprehensive approach to veteran employment, retention, and support. Roberts & Ryan joins a select group of top-performing employers nationwide that serve as role models for veteran-focused workforce development. “Roberts & Ryan has demonstrated exceptional support for veterans and the military-connected community, earning the organization one of the most prestigious awards possible in the VETS Indexes Employer Awards program,” said George Altman, president of VETS Indexes. “Roberts & Ryan is among the very best veteran employers, and its program can serve as a model for others.” Roberts & Ryan’s recognition highlights the firm’s ongoing efforts to support service members transitioning to civilian careers. As a veteran-founded company, Roberts & Ryan understands the unique strengths and experiences veterans bring to the workforce and actively integrates that perspective into its hiring practices, workplace culture, and community outreach. “As a Service-Disabled Veteran-Owned Business, supporting the military-connected community is part of our DNA,” said Edward D’Alessandro, CEO at Roberts & Ryan. “This award reflects our deep commitment to honoring those who serve and not just through employment, but through opportunity, growth, and lasting impact.” The VETS Indexes 5-star Employer award was granted on April 11, 2025 Recipients of the VETS Indexes Employer Awards are selected based on their responses to VETS Indexes’ groundbreaking survey, which examines the most important veteran employment metrics via a granular, objective, and data-focused questionnaire. There was no compensation paid or received for consideration of the award. To view the full list of 2025 VETS Indexes Employer Awards recipients, visit: https://vetsindexes.com/award-results-2025 About Roberts and Ryan, Inc. Roberts & Ryan, Inc. is a Service-Disabled Veteran Owned (SDVO) broker-dealer with execution capabilities in the capital markets, equities, and fixed-income trading. The firm was founded in 1987 by a United States Marine Corps Vietnam combat veteran and Purple Heart recipient. With over $2.38 million in committed donations, Roberts & Ryan is active in donating to charitable foundations that make significant positive impacts in the lives of Veterans and their families, focusing primarily on general wellness, mental health, and career transition. To learn more about Roberts & Ryan, please visit www.roberts-ryan.com. Securities are offered by Roberts & Ryan Inc., member FINRA | SIPC | MSRB | NYSE | NASDAQ. Contact Details Michael C. Del Priore +1 646-859-4061 mdelpriore@roberts-ryan.com Company Website https://www.roberts-ryan.com

April 29, 2025 09:10 AM Eastern Daylight Time

TempoPay Rx Launches to Help Bridge the Prescription Drug Affordability Gap

TempoPay

TempoPay, a subsidiary of industry-leading healthcare financing and payments solutions provider PayMedix, today announced the availability of TempoPay Rx, a financing solution designed to address the growing trend in prescription drug non-adherence across the country. “We are excited to bring TempoPay Rx to the market and help create simpler and more affordable access to prescription medications for our clients,” said Tom Policelli, CEO, PayMedix. “We have seen how decreasing financial barriers to medical care has improved health outcomes for members and financial results for our employer clients. Expanding this to include pharmacy costs is the next logical step to help consumers get the care they need when they need it." With prescription drug prices rising at more than twice the rate of inflation, access and affordability for the nearly two-thirds (61%) of Americans who take prescription medications has become a serious concern. More than half (55%) of Americans report being worried about affording their prescription drug costs and nearly one-third (31%) have avoided taking medications as prescribed due to cost. TempoPay Rx is a card-based financing solution that provides enrolled employees with access to interest-free financing for prescription medications for themselves and their dependents. Employees of participating employers can receive the benefit with no credit checks or income requirements. The program offers interest and fee-free financing on a revolving basis, with flexible repayment terms made either via bank account or payroll deductions. TempoPay Rx members can access their benefit via the TempoPay app and can use either their mobile wallet or a TempoPay VISA® card to pay. PayMedix has been providing interest-free financing for in-network medical care for over 15 years. It recently completed a comprehensive study of the long-term benefits of its innovative payments solution on 45,000 active members in Wisconsin and found that not only was in-patient hospital care of PayMedix members lower than national averages by 8%, but employer medical trend increases were nearly 40% lower than the national average. “Making prescription medications more accessible by lowering the financing barriers ultimately brings the cost of healthcare down,” said Brian Marsella, President, PayMedix. “It’s a fact that medication non-adherence leads to worsening health, increased emergency room visits and hospital admissions, driving costs higher. Our clients have experienced enormous value from our medical care financing and have asked for expanded support for prescription medications. We’re proud to extend TempoPay Rx to all of our HPS employer groups this summer. Employers can further enhance this benefit with additional coverage for more funding or types of needs, ensuring comprehensive support for their employees.” TempoPay Rx will be available for all PayMedix employer groups in the HPS medical network at no additional cost beginning August 2025, with $500 in revolving funds to help subscribers afford prescription medications for themselves and their dependents. In addition to TempoPay Rx, interest-free financing for medical, dental and vision care is available through the TempoPay platform for any employer nationwide. More information can be found at www.tempopay.com. About TempoPay TempoPay partners with employers to help their employees manage their medical costs with interest-free financing and flexible repayment options. With the TempoPay Visa® card employees can take control of how they pay for healthcare without added stress, providing simple access to the financial security needed for happier, healthier lives. About PayMedix PayMedix is the only company solving the problem of high out-of-pocket costs for everyone -- providers, patients, employers, and TPAs. PayMedix is changing how people access, use, and pay for healthcare by guaranteeing payments to providers and financing for all patients. PayMedix has processed more than $5 billion in medical payments for hospital systems and physician practices and can be implemented in conjunction with any PPO or HMO network. Contact Details TempoPay Hattie Ninteau hninteau@hps.md Company Website https://www.tempopay.com

April 29, 2025 09:00 AM Eastern Daylight Time

NAVEX Appoints New International EVP and Managing Director

NAVEX Global

NAVEX, the global leader in integrated risk and compliance management software, today announced Yuval Grauer as International EVP and Managing Director. He will lead business growth in Europe, the Middle East, and Africa (EMEA) and the Asia-Pacific region (APJ), becoming an integral member of the executive leadership team. Based in London, Grauer will spearhead initiatives to extend NAVEX solutions across high growth markets. He brings years of strategic insight from his time at McKinsey & Company, combined with deep operational expertise and a proven track record of growing and scaling global businesses of all sizes. He holds an MBA from Columbia University in New York, a Master of Engineering from Universitat Politècnica de Catalunya, and continues studies in Economics at the Universitat de Barcelona. “We are delighted to have Yuval join our leadership team,” said Andrew Bates, Chief Executive Officer, NAVEX. “His strong strategic leadership skills are an excellent match for NAVEX as we rapidly scale throughout EMEA and APJ regions. He joins NAVEX at a pivotal time of growth, bringing the vision and expertise needed to seamlessly drive international operations to achieve our global strategy.” “I am excited to join NAVEX at such an important time for its international business. I look forward to driving strategic expansion across the regions and empowering customers to succeed as they navigate increasingly complex regulatory environments,” said Grauer. International markets are integral to NAVEX’s overall business strategy as the company continues to invest significantly in products and resources in EMEA and APJ regions to drive smart, sustained growth and success. In January, the business announced the grand opening of its permanent Global Capability Center (GCC) in Bangalore, India. With a presence now across America, Europe and Asia, NAVEX’s impact spans the globe, providing over 88 million employees at more than 13,000 organisations with a safer place to work. Trusted by over 13,000 organizations, including 70 percent of Fortune 100 and 500 companies, NAVEX is the global leader in risk and compliance solutions. Its NAVEX One platform strengthens risk and compliance programs, empowering organizations with unparalleled industry benchmark data and insights. NAVEX One provides a 360-degree view of enterprise, third party and ecosystem risk for enhanced regulatory compliance and proactive risk management. Based in Lake Oswego, OR, with a global presence, NAVEX continues to shape the future of governance, risk and compliance. Visit our blog or follow us on LinkedIn, Facebook, and YouTube. Contact Details NAVEX +1 617-388-5773 anita.lo@navex.com Company Website https://navex.com

April 29, 2025 09:00 AM Eastern Daylight Time

Consulta Remédios Selects Kevel’s Retail Media Cloud to Power its Next-Generation Advertising Platform

Kevel

Kevel, the leading provider of API-based retail media ad serving technology, today announced that Consulta Remédios, Brazil's largest medicine price comparison platform, has selected Kevel's Retail Media Cloud™ to power the development and enhancement of its in-house retail media network. This partnership marks a significant step in Consulta Remédios' digital transformation strategy, enabling the platform to offer more targeted and effective advertising solutions to its partners and underscores Kevel's growing presence in the Latin American market. By leveraging Kevel's cutting-edge technology, Consulta Remédios aims to create a bespoke advertising platform that aligns with its commitment to providing accessible healthcare information and competitive pricing to Brazilian consumers. The new retail media network will enable Consulta Remédios to offer its advertising partners more targeted and effective ways to reach customers while enhancing the user experience for its millions of monthly visitors. Working closely with the Kevel team, Consulta Remédios will leverage the Retail Media Cloud™ to create seamless integrations of retail media offerings into its digital strategies. This collaboration will emphasize enhancements to the user experience across both owned and off-site channels through personalization and relevant product recommendations, utilizing Consulta Remédios' unique first-party data. James Avery, Founder and CEO of Kevel, commented, "We're excited to support Consulta Remédios as they expand their retail media capabilities. Their decision to build their retail media network on our Retail Media Cloud™ demonstrates the value in our flexible API-first platform - empowering them to quickly launch customized ad campaigns, unlock rich first-party targeting and deliver highly personalized ad experiences. We're excited to help Consulta Remédios create a truly unique advertising experience that reflects their mission of making healthcare more accessible and affordable in Brazil." Key benefits of the Consulta Remédios-Kevel partnership include: Advanced Targeting: Consulta Remédios can now harness its rich first-party data to create AI-powered customer segments, enabling highly personalized advertising campaigns. Diverse Ad Formats: Kevel's platform supports a wide range of ad units, allowing Consulta Remédios to implement native ads, sponsored listings, and contextual displays seamlessly. Rapid Deployment: With Kevel's technology, Consulta Remédios can launch custom retail media campaigns in as little as 14 days, ensuring agility during peak health seasons and promotional periods. Data Compliance and Security: Kevel's industry-leading data compliance features allow Consulta Remédios to confidently use its customer data while maintaining strict privacy standards. Improved Advertiser ROI: More precise targeting and diverse ad formats are expected to significantly enhance returns for Consulta Remédios' advertising partners. Paulo Vion, CEO at Consulta Remédios, said, "At Consulta Remédios, we're always looking for innovative ways to improve our users' experience and provide value to our advertising partners. Kevel's Retail Media Cloud™ gives us the tools and flexibility we need to build a retail media network that's uniquely tailored to the healthcare industry. We're excited about the possibilities this opens up for our business, our users, and our advertising partners." The implementation of Kevel's Retail Media Cloud™, facilitated in collaboration with local partner ShopperMedia, is expected to be completed in phases over the coming months, with the first ad placements going live later this year. About Kevel Kevel is transforming the retail media space with its cutting-edge, AI-driven ad tech infrastructure APIs that power the Retail Media Cloud™. This groundbreaking solution combines the power of AI insights with API-based technology, allowing multi-brand retailers to build dynamic, customizable ad platforms while maintaining full control of their first-party data. With Kevel, retailers can deliver personalized shopper experiences, optimize ad targeting, and unlock predictive insights to stay ahead in an ever-evolving market. Kevel's mission is rooted in the belief that every digital retailer should have the tools to create their own tailored ad platform, comparable to industry leaders like Amazon. Harnessing the power of AI for data-driven decision-making, Kevel has helped leading brands such as Chewy, The Home Depot, Edmunds, Lyft, Delivery Hero, Sonae, Slickdeals, and others launch impactful retail media networks—fostering innovation and unlocking new revenue opportunities.Learn more about how Kevel is transforming retail media at www.kevel.com. About Consulta Remédios Consulta Remédios is Brazil’s leading pharmaceutical marketplace platform, helping millions of Brazilians find the best prices on both prescription and over-the-counter medications. It also stands out as the largest aggregator of small, medium, and large pharmacy retailers in the country. With a mission to make healthcare more accessible and affordable, the platform provides transparent information on pricing, drug interactions, and nearby pharmacy locations. It serves as an essential tool for both consumers and healthcare professionals, supporting more informed decisions when purchasing medications. Contact Details Kevel Jennifer Choo Director of Marketing +1 973-343-8819 jchoo@kevel.com

April 29, 2025 09:00 AM Eastern Daylight Time

Novidea Provides Insights on the Five Key Challenges MGAs Navigate Amid Insurance Industry Evolution

Novidea

Novidea, provider of the cloud-native insurance management platform for brokers, agents, MGAs, and hybrid fronting carriers, today released new insights on the evolving MGA market, spotlighting the operational challenges shaping the sector’s future. Drawing on industry research, customer feedback, and engagement with global insurance stakeholders, Novidea experts identified the critical obstacles MGAs must overcome to sustain growth. MGAs are pivotal in bridging coverage gaps and driving market expansion. Research from Conning reveals that MGA premiums in the U.S. surpassed $102 billion, while The Actuarial Post reports $5.7 billion in the UK — marking continued momentum. However, as demand surges, MGAs have a growing business opportunity and need to navigate complexity, maintain agility, and balance growth with long-term profitability. “MGAs play a critical role in managing emerging risks and fueling market growth, but operational inefficiencies and fragmented and/or legacy technologies continue to hinder their full potential,” said Jeff Heine, Chief Revenue Officer at Novidea. “To thrive in this environment, MGAs must equip themselves with the tools and strategies to address these challenges and seize new opportunities. Novidea delivers advanced analytics and actionable insights that translate into real-time business intelligence, enabling MGAs to drive growth.” Five key challenges facing MGAs today are: Limited Business Insights – Poor data management, limited access to quality data and deficient reporting capabilities prevent many MGAs from gaining insights into business performance, making it hard to make smart decisions for the future, satisfy capacity providers and meet growth targets. Fragmented Systems and Collaboration Challenges – Relying on disconnected platforms complicates operations, reduces collaboration, and can cause ineffective communication between insurers, brokers, and third-party solutions providers. The inability to streamline and access real-time data across departments, anytime, from anywhere can hold MGAs back from optimally managing their businesses. Core Platform Limitations – Many MGAs run the risk of adopting outdated systems that lack critical functionalities and flexibility, limiting their ability to adapt to business opportunities and possibly falling behind competition. Regulatory Compliance – Keeping pace with evolving regulations introduces significant operational risks for under-resourced MGAs. Need for Market Adaptability – Many MGAs lack agile workflows and tools necessary to efficiently launch new commercial lines of business and adapt to changing conditions without disrupting current operations. MGAs must find innovative ways to overcome these obstacles while maintaining focus on client needs and market opportunities. A modern insurance management platform is essential for MGAs looking to thrive in a competitive market. These platforms enable organizations to scale efficiently, respond swiftly to market changes, and enhance service delivery, positioning them for sustained success in the evolving insurance landscape. Novidea's platform fully streamlines front, middle, and back offices, boosting operational efficiency while providing a seamless digital experience. MGAs can manage anything from submissions, quote-to-bind, policy issuance, and premium processing, to claims and accounting in one platform. Flexible Bordereaux production and value-driven reporting means clients can easily differentiate and demonstrate value to capacity providers and trading partners. Novidea’s open API infrastructure means you can tailor your business by adding functionality, capabilities, and services as you grow, capitalizing on a continuously evolving landscape. MGAs benefit from a 360-degree view of any account or portfolio of business, making it easy to make fast, accurate and informed business decisions based on valuable data insights across every phase of the insurance supply chain. Come meet with Novidea's experts at TIN Delegated Authority Strategy Day on 29th April in London or at Target Markets on May 6-8 in Dallas, TX. About Novidea Novidea is the leading Insurtech provider of a cloud-native, data-driven insurance management system. With its open API architecture, Novidea enables brokers, agents, MGAs, and carriers to modernise and manage the customer journey end-to-end and drive growth across the entire insurance distribution lifecycle. Novidea's streamlined and automated platform fully integrates front, middle, and back offices. The Novidea platform boosts operational efficiency while providing a seamless digital experience for team members and customers alike. Insurance businesses benefit from a 360-degree view of customers and policies and can access data and actionable insights anytime, anywhere, and on any device. In 2024, Novidea acquired Docomotion, a leading Document Generation platform. The company currently serves more than 350 customers worldwide. Contact Details Michelle Barry +1 603-809-2748 Michelle.barry@chameleon.co Elliot Lane +44 20 7623 2368 FWDNovidea@fwdconsulting.co.uk Company Website https://novidea.com/

April 29, 2025 03:00 AM Eastern Daylight Time

1 ... 4 5 6 7 8 ... 3870